Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

• Main Authors: Milana Bergamino Sirvén (Author), Adela Fernández-Ortega (Author), Agostina Stradella (Author), Idoia Morilla (Author), Catalina Falo (Author), Silvia Vázquez (Author), Roser Castany (Author), Rafael Villanueva (Author), Sabela Recalde (Author), Valentí Navarro Pérez (Author), Miguel Gil-Gil (Author), Sonia Pernas (Author)
• Format: Book
• Published: BMC, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Eribulin improves survival in pre-treated HER2-negative advanced breast cancer (ABC). However, limited data exist on co-morbidities and central nervous system (CNS) efficacy. The purpose of this study was to review eribulin's efficacy and safety in everyday clinical practice...